INDSWFTLAB

IND-SWIFT LABORATORIES

Small Cap BSE: 532305 NSE: INDSWFTLAB
₹64.65
0.05 (0.08%)
As on 30 November, 2022 | 22:58

Ind-Swift Laboratories Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in IND-SWIFT LABORATORIES

Start SIP

Ind-Swift Laboratories Share Price

Ind-Swift Laboratories Share Returns

  • Over 1 Month 20.17%
  • Over 3 Month 8.2%
  • Over 6 Month 16.8%
  • Over 1 Year -13.51%

Ind-Swift Laboratories Key Statistics

P/E Ratio -1897
PEG Ratio 18.8
Market Cap Cr 382
Price to Book Ratio 1
EPS -0.4
Dividend 0
Relative Strength Index 61.21
Money Flow Index 69.2
MACD Signal 2.11
Average True Range 2.37

Ind-Swift Laboratories Investment Rating

  • Master Rating:
  • Ind-Swift Labs. (Nse) has an operating revenue of Rs. 1,143.67 Cr. on a trailing 12-month basis. An annual revenue growth of 18% is outstanding, Pre-tax margin of 1% needs improvement, ROE of -0% is poor and needs improvement. The company has a high debt to equity of 210%, which can be a reason to worry. The stock from a technical standpoint is trading close to its 200DMA and around 10% above its 50DMA. It needs to stay above the 200DMA levels to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 15 which is a POOR score indicating inconsistency in earnings, a RS Rating of 42 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 94 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Institutional holding has declined in the last reported quarter is a negative sign. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Ind-Swift Laboratories Financials
IndicatorSep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021
Oper Rev Qtr Cr 288272276240230242218
Operating Expenses Qtr Cr 231219241187175191177
Operating Profit Qtr Cr 57533554555141
Depreciation Qtr Cr 16168221141428
Interest Qtr Cr 24242324242424
Tax Qtr Cr 001400021
Net Profit Qtr Cr 2420-63152419-29

Ind-Swift Laboratories Technicals

EMA & SMA

Current Price
64.65
0.05 (0.08%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • 62.36
  • 50 Day
  • 60.04
  • 100 Day
  • 60.13
  • 200 Day
  • 62.19
  • 20 Day
  • 62.04
  • 50 Day
  • 58.33
  • 100 Day
  • 59.12
  • 200 Day
  • 62.05

Ind-Swift Laboratories Resistance and Support

PIVOT
₹64.55
Resistance
First Resistance 65.1
Second Resistance 65.6
Third Resistance 66.16
RSI 61.21
MFI 69.2
MACD Single Line 2.11
MACD 2.15
Support
First Resistance 64.05
Second Resistance 63.5
Third Resistance 63

Ind-Swift Laboratories Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 43,772 3,442,668 78.65
Week 72,730 5,102,723 70.16
1 Month 125,601 7,582,524 60.37
6 Month 52,991 3,121,690 58.91

Ind-Swift Laboratories Result Highlights

Ind-Swift Laboratories Synopsis

NSE-Medical-Generic Drugs

Ind-Swift Laboratori is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 988.09 Cr. and Equity Capital is Rs. 59.81 Cr. for the Year ended 31/03/2022. Ind-Swift Laboratories Ltd. is a Public Limited Listed company incorporated on 04/01/1995 and has its registered office in the State of Chandigarh, India. Company’s Corporate Identification Number(CIN) is L24232CH1995PLC015553 and registration number is 015553.
Market Cap 382
Sales 1,075
Shares in Float 3.43
No of funds 4
Yield
Book Value 0.89
U/D Vol ratio 0.7
LTDebt / Equity 192
Alpha -0.05
Beta 0.88

Ind-Swift Laboratories

Owner NameSep-22Jun-22Mar-22Dec-21
Promoters 42%42%42%
Foreign Portfolio Investors 0.06%
Individual Investors 29.06%29.55%29.31%
Others 28.94%28.45%28.63%

Ind-Swift Laboratories Management

Name Designation
Mr. N R Munjal Chairman & Managing Director
Mr. Himanshu Jain Joint Managing Director
Mr. Rishav Mehta Executive Director
Mr. Sahil Munjal Executive Director
Ms. Neerja Chathley Independent Director
Mr. S P Sharma Independent Director
Mr. Rajinder Kumar Gupta Independent Director
Dr. Ashwani Kumar Vig Independent Director

Ind-Swift Laboratories Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Ind-Swift Laboratories Corporate Action

Date Purpose Remarks
2022-11-08 Quarterly Results
2022-08-10 Quarterly Results
2022-05-28 Audited Results
2022-02-08 Quarterly Results
2021-11-01 Quarterly Results

Ind-Swift Laboratories MF Shareholding

Name Amount(cr)
Motilal Oswal S&P BSE Healthcare ETF 6

Ind-Swift Laboratories FAQs

What is Share Price of Ind-Swift Laboratories ?

Ind-Swift Laboratories share price is ₹64 As on 30 November, 2022 | 22:44

What is the Market Cap of Ind-Swift Laboratories ?

The Market Cap of Ind-Swift Laboratories is ₹382 Cr As on 30 November, 2022 | 22:44

What is the P/E ratio of Ind-Swift Laboratories ?

The P/E ratio of Ind-Swift Laboratories is -1897 As on 30 November, 2022 | 22:44

What is the PB ratio of Ind-Swift Laboratories ?

The PB ratio of Ind-Swift Laboratories is 1 As on 30 November, 2022 | 22:44

Q2FY23